Literature DB >> 18314501

Evidence that tRNA modifying enzymes are important in vivo targets for 5-fluorouracil in yeast.

Marie Gustavsson1, Hans Ronne.   

Abstract

We have screened a collection of haploid yeast knockout strains for increased sensitivity to 5-fluorouracil (5-FU). A total of 138 5-FU sensitive strains were found. Mutants affecting rRNA and tRNA maturation were particularly sensitive to 5-FU, with the tRNA methylation mutant trm10 being the most sensitive mutant. This is intriguing since trm10, like many other tRNA modification mutants, lacks a phenotype under normal conditions. However, double mutants for nonessential tRNA modification enzymes are frequently temperature sensitive, due to destabilization of hypomodified tRNAs. We therefore tested if the sensitivity of our mutants to 5-FU is affected by the temperature. We found that the cytotoxic effect of 5-FU is strongly enhanced at 38 degrees C for tRNA modification mutants. Furthermore, tRNA modification mutants show similar synthetic interactions for temperature sensitivity and sensitivity to 5-FU. A model is proposed for how 5-FU kills these mutants by reducing the number of tRNA modifications, thus destabilizing tRNA. Finally, we found that also wild-type cells are temperature sensitive at higher concentrations of 5-FU. This suggests that tRNA destabilization contributes to 5-FU cytotoxicity in wild-type cells and provides a possible explanation why hyperthermia can enhance the effect of 5-FU in cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18314501      PMCID: PMC2271368          DOI: 10.1261/rna.966208

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  39 in total

1.  Loss of tRNA 5-methyluridine methyltransferase and pseudouridine synthetase activities in 5-fluorouracil and 1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur)-treated Escherichia coli.

Authors:  D A Frendewey; D M Kladianos; V G Moore; I I Kaiser
Journal:  Biochim Biophys Acta       Date:  1982-04-26

2.  Catalytic mechanism and inhibition of tRNA (uracil-5-)methyltransferase: evidence for covalent catalysis.

Authors:  D V Santi; L W Hardy
Journal:  Biochemistry       Date:  1987-12-29       Impact factor: 3.162

Review 3.  Metabolism and mechanism of action of 5-fluorouracil.

Authors:  W B Parker; Y C Cheng
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

4.  A conserved aspartate of tRNA pseudouridine synthase is essential for activity and a probable nucleophilic catalyst.

Authors:  L Huang; M Pookanjanatavip; X Gu; D V Santi
Journal:  Biochemistry       Date:  1998-01-06       Impact factor: 3.162

5.  Interactions of transfer RNA pseudouridine synthases with RNAs substituted with fluorouracil.

Authors:  T Samuelsson
Journal:  Nucleic Acids Res       Date:  1991-11-25       Impact factor: 16.971

6.  RNA-directed actions of 5-fluorouridine in hemin stimulated K-562 erythroleukemia cells.

Authors:  R Heimer; A C Sartorelli
Journal:  Cancer Biochem Biophys       Date:  1992-05

7.  Increased cytotoxicity of low-dose, long-duration exposure to 5-fluorouracil of V-79 cells with hyperthermia.

Authors:  Y Kido; H Kuwano; Y Maehara; M Mori; H Matsuoka; K Sugimachi
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

8.  TOM1p, a yeast hect-domain protein which mediates transcriptional regulation through the ADA/SAGA coactivator complexes.

Authors:  A Saleh; M Collart; J A Martens; J Genereaux; S Allard; J Cote; C J Brandl
Journal:  J Mol Biol       Date:  1998-10-09       Impact factor: 5.469

9.  The yeast tRNA:pseudouridine synthase Pus1p displays a multisite substrate specificity.

Authors:  Y Motorin; G Keith; C Simon; D Foiret; G Simos; E Hurt; H Grosjean
Journal:  RNA       Date:  1998-07       Impact factor: 4.942

10.  Incorporation of 5-fluorouracil into U2 snRNA blocks pseudouridylation and pre-mRNA splicing in vivo.

Authors:  Xinliang Zhao; Yi-Tao Yu
Journal:  Nucleic Acids Res       Date:  2006-12-14       Impact factor: 16.971

View more
  44 in total

Review 1.  tRNA biology charges to the front.

Authors:  Eric M Phizicky; Anita K Hopper
Journal:  Genes Dev       Date:  2010-09-01       Impact factor: 11.361

2.  Systematic identification of gene annotation errors in the widely used yeast mutation collections.

Authors:  Taly Ben-Shitrit; Nir Yosef; Keren Shemesh; Roded Sharan; Eytan Ruppin; Martin Kupiec
Journal:  Nat Methods       Date:  2012-02-05       Impact factor: 28.547

Review 3.  Diversity in mechanism and function of tRNA methyltransferases.

Authors:  William E Swinehart; Jane E Jackman
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

4.  The anti-cancer drug 5-fluorouracil affects cell cycle regulators and potential regulatory long non-coding RNAs in yeast.

Authors:  Bingning Xie; Emmanuelle Becker; Igor Stuparevic; Maxime Wery; Ugo Szachnowski; Antonin Morillon; Michael Primig
Journal:  RNA Biol       Date:  2019-03-20       Impact factor: 4.652

5.  Mechanistic features of the atypical tRNA m1G9 SPOUT methyltransferase, Trm10.

Authors:  Aiswarya Krishnamohan; Jane E Jackman
Journal:  Nucleic Acids Res       Date:  2017-09-06       Impact factor: 16.971

6.  Emerging roles of novel small non-coding regulatory RNAs in immunity and cancer.

Authors:  Domenico Rosace; Judith López; Sandra Blanco
Journal:  RNA Biol       Date:  2020-03-18       Impact factor: 4.652

Review 7.  Transfer RNA methytransferases and their corresponding modifications in budding yeast and humans: activities, predications, and potential roles in human health.

Authors:  William L Towns; Thomas J Begley
Journal:  DNA Cell Biol       Date:  2011-12-22       Impact factor: 3.311

8.  The yeast rapid tRNA decay pathway competes with elongation factor 1A for substrate tRNAs and acts on tRNAs lacking one or more of several modifications.

Authors:  Joshua M Dewe; Joseph M Whipple; Irina Chernyakov; Laura N Jaramillo; Eric M Phizicky
Journal:  RNA       Date:  2012-08-15       Impact factor: 4.942

Review 9.  Role of RNA modifications in cancer.

Authors:  Isaia Barbieri; Tony Kouzarides
Journal:  Nat Rev Cancer       Date:  2020-04-16       Impact factor: 60.716

10.  Expanding the yeast prion world: Active prion conversion of non-glutamine/asparagine-rich Mod5 for cell survival.

Authors:  Genjiro Suzuki; Motomasa Tanaka
Journal:  Prion       Date:  2012-11-01       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.